PolyPeptide Group AG (SWX:PPGN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
20.10
-0.50 (-2.43%)
Mar 3, 2025, 5:31 PM CET
28.43%
Market Cap 679.46M
Revenue (ttm) 311.55M
Net Income (ttm) -27.50M
Shares Out 32.98M
EPS (ttm) -0.84
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 97,691
Average Volume 41,823
Open 20.60
Previous Close 20.60
Day's Range 20.00 - 20.75
52-Week Range 15.48 - 35.80
Beta 1.03
RSI 26.10
Earnings Date Mar 11, 2025

About PolyPeptide Group AG

PolyPeptide Group AG operate as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of peptide-based therapies for metabolic disorders, including the GLP-1 receptor agonist drugs for the treatment of type 2 diabetes, obesity, and other co-morbidities, as well as oncology, hormonal disorde... [Read more]

Sector Healthcare
Founded 1952
Employees 1,273
Stock Exchange SIX Swiss Exchange
Ticker Symbol PPGN
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.